United States· US:67172-503_b1be7047-7e1e-4863-9132-a16688405721
Clear Eyes Sensitive
A medicinal product containing phenylephrine hydrochloride; glycerin, registered in United States by Prestige Brands Holdings, Inc..
Checked against FDA National Drug Code directory (United States) on
Informational only — not a medical device.
The record
At a glance
FDA National Drug Code directory (United States)- Active substance
- PHENYLEPHRINE HYDROCHLORIDE; GLYCERIN
- Manufacturer
- Prestige Brands Holdings, Inc.
- Country
- United States (US)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- FDA National Drug Code directory (United States)
- Last checked
- September 6, 2026
Packs & prices · 2
- ndc1167172503151 BOTTLE, DROPPER in 1 CARTON (67172-503-15) / 15 mL in 1 BOTTLE, DROPPER
- ndc1167172-503-15
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FDA National Drug Code directory (United States). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f26b5227-c6e0-4bfd-9207-fe19c989fd1a GET /v1/drugs/f26b5227-c6e0-4bfd-9207-fe19c989fd1a?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"route": "OPHTHALMIC",
"source": "ndc",
"strength": "2; 2.5",
"substance": "PHENYLEPHRINE HYDROCHLORIDE; GLYCERIN",
"productndc": "67172-503",
"dosage_form": "SOLUTION/ DROPS",
"dea_schedule": null,
"strength_unit": "mg/mL; mg/mL",
"application_number": "M018",
"marketing_category": "OTC MONOGRAPH DRUG"
}See everything about phenylephrine hydrochloride; glycerin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.